Actavis Puts Up $8.5B For Warner Chilcott

Law360, New York (May 20, 2013, 12:51 PM EDT) -- Actavis Inc. will acquire Ireland-based Warner Chilcott PLC, inking a $8.5 billion deal that expands its clout in generic specialty medicine by creating a new trans-Atlantic pharmaceutical giant, Actavis announced Monday.

The New Jersey-based generic-drug maker will buy up approximately $5 billion in Warner Chilcott's outstanding stock, creating a new company incorporated in Ireland — tentatively called Actavis PLC, Actavis announced in a statement Monday. The two companies said earlier this month that they were mulling over a merger, which will form the third-largest specialty pharmaceutical...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.